Method for synthesizing oxcarbazepine key intermediate

Through improved synthesis route, the problems of low reaction activity and high cost in oxcarbazepine synthesis are solved by using NBS bromination, acetic acid lysis, alkaline hydrolysis and copper catalytic oxidation steps, and the high-efficiency and low-cost oxcarbazepine intermediates are achieved. Preparation of body and target.

CN118994010AActive Publication Date: 2024-11-22衢州市浙工大生态工业创新研究院 +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411060514.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-22
Estimated Expiration
2044-08-05

AI Technical Summary

Technical Problem

In the existing oxcarzepine synthesis process, dibromide eliminates the tandem alcoholylation step in sodium methoxide methanol solution with low reaction activity, long time, low yield, and side reactions and high cost problems.

Method used

Using 5-cyano-10,11-dihydro-5H-diphenyl[b,f] azazola as the starting material, it was gradually prepared by NBS bromination, acetic acid decomposition, alkaline hydrolysis, and copper catalytic oxidation. Ocaxipine key intermediate and Ocaxipine is obtained through catalytic hydrolysis of sulfuric acid, avoiding side reactions and a high-cost oxidation system.

Benefits of technology

It significantly improves reaction selectivity and yield, reduces production costs, simplifies post-processing steps, and achieves efficient and low-cost oxcarbazepine synthesis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994010A_ABST
    Figure CN118994010A_ABST
Patent Text Reader

Abstract

The invention discloses a method for synthesizing an oxcarbazepine key intermediate, which comprises the following steps: carrying out acetic acid hydrolysis on a compound 2 serving as a raw material to obtain a compound 3, carrying out series hydrolysis to obtain a hydroxylate, namely a compound 4, and carrying out copper-catalyzed air oxidation on the hydroxylate to obtain a carbonylate, namely a compound 5, namely the oxcarbazepine key intermediate. The process disclosed by the invention has the advantages that the synthesis steps are short, the used materials are cheap and easy to obtain, the conditions of each step are mild, and the yield is high; compared with the traditional direct hydrolysis process of brominated substances, the process of acetic hydrolysis and hydrolysis of brominated substances can effectively inhibit alkalinity elimination of brominated substances, and the hydrolysis reaction selectivity is remarkably improved; compared with a traditional sodium hypochlorite / TEMPO oxidation process, the method adopting oxygen as an oxygen source in the step of preparing the carbonyl compound through hydroxylate oxidation has definite advantages in economy and safety.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for synthesizing a key intermediate of oxcarbazepine. Background Art

[0002] Oxcarbazepine (OCBZ), chemical name 10,11-dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide, is a 10-keto derivative of carbamazepine. Due to its easy absorption, low toxicity, and no liver enzyme induction, it is suitable as a first-line anti-epileptic drug and is widely used by epilepsy patients around the world. At the same time, oxcarbazepine can also be used to treat trigeminal neuralgia, central nervous system uremia, Parkinson's disease, etc.

[0003] At present, the synthetic route of oxcarbazepine can be divided into four categories according to its starting materials: iminodibenzyl method, iminostilbene method, carbamazepine method and 10-methoxyiminostilbene method. Each method has significant advantages and disadvantages. Among them, the synthetic route that has been studied more and is relatively mature mainly uses iminodibenzyl as the raw material, and undergoes N-chloroformylation, benzyl bromination, elimination to obtain olefin, olefin and liquid bromine addition to obtain dibromide, dibromide is eliminated in sodium methoxide methanol solution in series with alcoholysis to obtain enether, enether is N-chloroformylated, aminolyzed, and finally enether is rearranged by acid-catalyzed ether bond cleavage to obtain the target product oxcarbazepine. In general, the process route has a long number of steps, and the reaction involves two brominations. Among them, the elimination and alcoholysis of dibromide in sodium methoxide methanol solution in series has the problems of low reaction activity, long time consumption and low yield. At the same time, the chloroformyl group is easily removed in this step, and the chloroformyl group needs to be reintroduced in the subsequent step, the atomic utilization rate is low, and the process has obvious defects. The specific reaction formula is as follows:

[0004]

[0005] Previously, two patent documents reported that oxcarbazepine was synthesized by four-step reaction using 5-cyano-10,11-dihydro-5H-diphenyl[b,f]azepine as raw material (U.S. Patent No. 6384217 and Chinese Patent No. 200810062785.X). U.S. Patent No. 6384217 used NBS as a bromination reagent and obtained the target product through benzyl bromination, alkaline hydrolysis, oxidation with calcium hypochlorite / TEMPO system, and sulfuric acid-catalyzed cyano hydrolysis. Chinese Patent No. 200810062785.X also used 5-cyano-10,11-dihydro-5H-diphenyl[b,f]azepine as raw material, liquid bromine as a bromination reagent, benzyl bromination, alkaline hydrolysis, oxidation with calcium hypochlorite / TEMPO system, and alkaline hydrogen peroxide system to achieve cyano hydrolysis to obtain the target product. In the above two patent routes, the direct alkaline hydrolysis step of benzyl bromide intermediate is used to prepare hydroxyl compounds. Studies have found that this step has serious elimination side reactions. When generating hydroxyl compounds, a large amount of elimination byproduct olefins will be generated at the same time, which increases the difficulty of post-reaction treatment and greatly reduces the reaction yield and increases the synthesis cost. In the step of preparing carbonyl compounds by oxidation of alcohols, sodium hypochlorite / TEMPO is used as the oxidation system to oxidize hydroxyl compounds to obtain carbonyl compounds, which is relatively costly and has certain safety risks. Summary of the invention

[0006] In view of the shortcomings of the prior art, the present invention provides a new, cheaper and feasible method for synthesizing a key intermediate of oxcarbazepine and a method for preparing oxcarbazepine. The method provided by the present invention comprises the following steps:

[0007] (1) Compound 1 (5-cyano-10,11-dihydro-5H-diphenyl[b,f]azepine) is used as a starting material, NBS is used as a bromination reagent, and BPO is used as an initiator, and the monobromide, i.e., compound 2, is obtained by benzylic bromination;

[0008] (2) Compound 2 is used as a raw material, and compound 3 is prepared by acetic acid hydrolysis in the presence of a base using acetic acid as a solvent;

[0009] (3) Compound 3 is used as a raw material and hydrolyzed under the action of a base to obtain compound 4;

[0010] (4) Compound 4 is used as a raw material and oxygen is used as an oxygen source to obtain carbonyl compound 5 by copper-catalyzed oxidation. Compound 5 is a key intermediate of oxcarbazepine;

[0011] (5) Compound 5 was used as raw material and sulfuric acid was used as catalyst to obtain the target compound 6 oxcarbazepine by acidic hydrolysis. The reaction formula is as follows:

[0012]

[0013] Furthermore, in step (1), 5-cyano-10,11-dihydro-5H-diphenyl[b,f]azepine is used as the starting material, and the specific process of synthesizing compound 2 by benzylic bromination is as follows: compound 1 is used as the starting material, the molar amount of compound 1 is 1 eq., 1.0-1.1 eq. NBS is used as the bromination reagent, 0.02-0.1 eq. BPO is used as the initiator, and the benzylic bromination is achieved in a carbon tetrachloride solvent to obtain compound 2.

[0014] Furthermore, the reaction of synthesizing compound 2 using compound 1 as the starting material has a reaction temperature of 55-65° C. until the reaction is monitored to be complete; after the reaction is completed, the following post-treatment steps are also included: cooling, filtering, concentrating the filtrate under reduced pressure, recrystallizing the concentrated residue with acetone, and filtering and collecting the solid to obtain compound 2.

[0015] Furthermore, in step (2), the synthesis of compound 3 is carried out using compound 2 as a starting material and acetic acid as a solvent in the presence of a base to obtain compound 3 by acetic acid hydrolysis; the base is selected from sodium hydroxide, lithium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, potassium phosphate, potassium carbonate, cesium carbonate, sodium acetate, potassium acetate, one or more of which are mixed in any ratio, and the molar ratio of the base to compound 2 is 1.0:1 to 2.0:1.

[0016] Furthermore, the acetic acid hydrolysis reaction is stirred at room temperature until the reaction is complete, and after the reaction is completed, the acetic acid solvent is recovered by decompression, and the residual liquid is directly used for the next reaction.

[0017] Furthermore, in step (3), the synthesis of compound 4 is obtained by hydrolysis in the presence of a base, the base is selected from sodium hydroxide, lithium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium acetate, potassium acetate, one or more of which are mixed in any ratio, the reaction solvent of the hydrolysis reaction is an organic solvent-water mixed solvent, the organic solvent is a low boiling point solvent miscible with water such as ethanol, methanol, tetrahydrofuran, acetonitrile, acetone, etc. At least one, the volume ratio of the organic solvent to water can be 1:0.5 to 2, the molar ratio of the base in the hydrolysis reaction to the raw material compound 2 in the previous step is 1.0:1 to 3.0:1, and the temperature range of the hydrolysis reaction is 20 to 80°C.

[0018] Furthermore, the synthesis of compound 4 uses compound 2 as the starting material to prepare compound 3 through acetic acid hydrolysis reaction. Compound 3 does not need to be purified. After the acetic acid hydrolysis reaction is complete, the solvent is recovered under reduced pressure and water is directly added and a base is added to undergo a hydrolysis reaction to obtain compound 4.

[0019] Furthermore, in step (4), the synthesis of compound 5 uses the synthesized compound 4 as a starting material, and in the presence of a copper salt ligand and a reaction solvent, oxygen is used as an oxygen source to obtain compound 5 by copper salt catalytic oxidation; the copper salt is selected from one of copper acetate, copper sulfate, copper hexafluorophosphate, copper trifluoroacetate, copper chloride, copper bromide, cuprous iodide, cuprous bromide, cuprous chloride, cuprous oxide, and cupric oxide, or a mixture of two or more of them in any ratio, and the amount of the copper salt used is 1% to 20% of the molar amount of compound 4, preferably 2.5% to 10%. The copper salt ligand is selected from dinitrogen ligands, that is, at least one of phenanthroline, ethylenediamine, N,N'-di-tert-butylethylenediamine, N,N'-dimethylethylenediamine, N,N,N',N'-tetramethylethylenediamine, bipyridine, bipyridine derivatives, cyclohexanediamine and cyclohexanediamine derivatives. The amount of the copper salt ligand is 100% to 200% of the molar amount of the copper salt; the reaction solvent is a common solvent such as at least one of dichloromethane, dichloroethane, chloroform, benzene, toluene, cyclohexane and ethyl acetate. The reaction temperature is 20 to 150°C, preferably 20 to 80°C.

[0020] Furthermore, the synthesis of compound 5 is carried out in the presence of DMAP, and the amount of DMAP used is 10-20% of the molar amount of compound 4.

[0021] Furthermore, after the reaction for synthesizing compound 5 is completed, the following post-treatment steps are also included: filtering, washing the filtrate with 0.5-2N hydrochloric acid and water, drying, concentrating, recrystallizing the residual liquid with chloroform solvent, and filtering and collecting the solid product to obtain compound 5.

[0022] Furthermore, in step (5), the synthesis of compound 6 uses the synthesized compound 5 as a starting material, and acid-catalyzed hydrolysis is carried out in an acetic acid solution with sulfuric acid as a catalyst to obtain the target product compound 6 oxcarbazepine. After the synthesis reaction of compound 6 is completed, the following post-treatment steps are also included: the reaction solution is poured into ice water, fully stirred, filtered, the filter cake is fully washed with ice water, and dried to obtain a solid product, namely compound 6.

[0023] The beneficial effects achieved by the present invention are:

[0024] (1) The reagents are cheap and readily available;

[0025] (2) The reaction conditions in each step are mild and the post-treatment is simple;

[0026] (3) The total yield is high, which has obvious advantages in production cost.

[0027] The significant differences and advantages of the synthesis process of the present invention over the above process are: ① the benzyl bromide intermediate is first subjected to acetic acid hydrolysis and then to dilute alkali hydrolysis to prepare a hydroxy compound, which can significantly suppress and eliminate side reactions and can achieve effective conversion of bromide to hydroxylate with nearly 100% reaction selectivity; ② in the step of oxidizing the hydroxy compound to ketone, oxygen is used as the oxygen source and copper-catalyzed oxidation is used instead of the sodium hypochlorite TEMPO system, so the reaction is clean and efficient, and has a great advantage in synthesis cost. DETAILED DESCRIPTION

[0028] The present invention is further described in detail below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto.

[0029] Example 1 Preparation of 5-cyano-10-bromo-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 2)

[0030] 4.4 g (20.0 mmol) of compound 1 was added with 20.0 mL of carbon tetrachloride and stirred to dissolve. 121 mg (0.5 mmol) of BPO and 3.56 g (20.0 mmol) of NBS were added. The mixture was kept at 60 ° C for 3 h until the reaction was complete. The mixture was cooled to 10 ° C and filtered. The filtrate was concentrated under reduced pressure and the residue was recrystallized from acetone to obtain 5.26 g of a light yellow solid, which was compound 2 (5-cyano-10-bromo-10,11-dihydrophenyl[b,f]azepine), with a yield of 88%.

[0031] Example 2. Preparation of 5-cyano-10-acetoxy-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 3)

[0032] 5.98 g (20.0 mmol) of compound 2 was dissolved in 16.0 mL of glacial acetic acid, cooled to 10 °C, 1.96 g (20.0 mmol) of potassium acetate was added, and the temperature was naturally raised to room temperature. Stirring was continued for about 1.5 h until the reaction was complete. The solvent was recovered under reduced pressure at a temperature below 30 °C, and the residual liquid was directly used in the next step without further purification.

[0033] Example 3. Preparation of 5-cyano-10-hydroxy-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 4)

[0034] The residual liquid obtained in Example 2 was dissolved in 20 mL of methanol, and 20 mL of 1 M NaOH aqueous solution was added. The mixture was kept warm at 40° C. for 2 h until the reaction was complete. Most of the methanol was evaporated under reduced pressure at a temperature not higher than 30° C., 60 mL of water was added, and the mixture was extracted twice with ethyl acetate. The mixture was dried and concentrated under reduced pressure. The residual liquid was recrystallized from acetone to obtain 4.54 g of a light yellow solid. The total yield of the two steps of acetic acid hydrolysis and hydrolysis was 96%.

[0035] Example 4. Preparation of 5-cyano-10-acetoxy-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 3)

[0036] 5.98 g (20.0 mmol) of compound 2 was dissolved in 32.0 mL of glacial acetic acid, and 4.24 g (40.0 mmol) of sodium carbonate was added. The temperature was naturally raised to room temperature, and stirring was continued for about 4 h until the reaction was complete. The solvent was recovered under reduced pressure at a temperature below 30 ° C. The residual liquid did not need further purification and was directly used in the next step.

[0037] Example 5. Preparation of 5-cyano-10-hydroxy-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 4)

[0038] The residual liquid obtained in Example 4 was dissolved in 40 mL of acetonitrile, 40 mL of water was added, 2.12 g (20.0 mmol) of sodium carbonate was added, and the mixture was kept at 80° C. for 2 h until the reaction was complete. Most of the acetonitrile was evaporated under reduced pressure at a temperature below 30° C., 60 mL of water was added, and the mixture was extracted twice with ethyl acetate, dried, and concentrated under reduced pressure. The residual liquid was recrystallized from acetone to obtain 4.20 g of a light yellow solid. The total yield of the two steps of acetic acid hydrolysis and hydrolysis was 89%.

[0039] Example 6. Preparation of 5-cyano-10-oxa-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 5)

[0040] 220 mg (1.0 mmol) of copper bromide and 220 mg (1.0 mmol) of bipyridine were added to 40 mL of anhydrous ethyl acetate and stirred for 10 min. 4.72 g (20.0 mmol) of compound 4 and 240 mg (2.0 mmol) of DMAP were added. 1 atm O2 was introduced and stirred at room temperature for 40 h until the reaction was complete. The mixture was filtered and the filtrate was washed with 1N HCl and water, dried and concentrated. The residual liquid was recrystallized from chloroform solvent to obtain 3.93 g of a light yellow solid with a yield of 84%.

[0041] Example 7. Preparation of 5-cyano-10-oxa-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 5)

[0042] 706 mg (2.0 mmol) of copper hexafluorophosphate and 288 mg (2.0 mmol) of diisopropylethylenediamine were added to 40 mL of anhydrous dichloromethane, stirred for 10 min, 4.72 g (20.0 mmol) of compound 4 was added, 480 mg (4.0 mmol) of DMAP was added, 1 atm O2 was introduced, and the mixture was kept at 50 °C for 10 h until the reaction was complete. The mixture was filtered, and the filtrate was washed with 1N HCl and water, dried, and concentrated. The residual liquid was recrystallized from chloroform solvent to obtain 4.31 g of a light yellow solid with a yield of 92%.

[0043] Example 8. Preparation of 5-cyano-10-oxa-10,11-dihydro-5H-diphenyl[b,f]azepine (Compound 5)

[0044] 45 mg (0.5 mmol) of cuprous chloride and 71 mg (0.5 mmol) of N,,N'-dimethylcyclohexanediamine were added to 50 mL of anhydrous toluene and stirred for 10 min. 4.72 g (20.0 mmol) of compound 4 was added, 1 atm O2 was introduced, and the mixture was kept at 80 °C for 24 h until the reaction was complete. The mixture was filtered, and the filtrate was washed with 1N HCl and water, dried, and concentrated. The residual liquid was recrystallized from chloroform solvent to obtain 2.2 g of a light yellow solid with a yield of 47%.

[0045] Example 9. Preparation of 10-oxa-10,11-dihydro-5H-diphenyl[b,f]azepine-5-carboxamide (Compound 6)

[0046] 4.68 g (20.0 mmol) of compound 5 was dissolved in 40.0 mL of glacial acetic acid, the temperature was controlled not to exceed 15 ° C, and 5 mL of 98% concentrated sulfuric acid was added dropwise. After the addition of concentrated sulfuric acid, the temperature was naturally raised and stirring was continued at room temperature for 8 h until the reaction was complete. The reaction solution was slowly poured into 300 g of ice water, fully stirred, filtered, and the filter cake was fully washed with ice water and dried to obtain 4.6 g of white solid, which was the target product oxcarbazepine, with a yield of 91%.

Claims

1. A method for synthesizing a key intermediate of oxcarbazepine, characterized in that Compound 2 is used as a raw material and subjected to acetic acid hydrolysis to obtain compound 3, which is then hydrolyzed in series to obtain a hydroxylate, namely compound 4. The hydroxylate is oxidized by copper-catalyzed air to obtain a carbonyl, namely compound 5, to obtain the key intermediate of oxcarbazepine. The reaction formula is as follows:

2. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 1, characterized in that: The synthesis of the compound 2 is carried out using N-cyano-10,11-dihydro-5H-diphenyl[b,f]azepine, i.e., compound 1, as a starting material, and obtaining a monobromide, i.e., compound 2, by benzylic bromination. The specific process is as follows: using compound 1 as a starting material, the molar amount of compound 1 is 1 eq., using 1.0-1.1 eq. of NBS as a bromination reagent, using 0.02-0.1 eq. of BPO as an initiator, and reacting in a carbon tetrachloride solvent to achieve benzylic bromination to obtain compound 2.

3. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 2, characterized in that: The reaction of synthesizing compound 2 using compound 1 as the starting material has a reaction temperature of 55-65° C. until the reaction is monitored to be complete; after the reaction is completed, the following post-treatment steps are also included: cooling, filtering, concentrating the filtrate under reduced pressure, recrystallizing the concentrated residue with acetone, and filtering and collecting the solid to obtain compound 2.

4. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 1, characterized in that: The synthesis of compound 3 is carried out using compound 2 as a starting material and acetic acid as a solvent to obtain compound 3 by acetic acid hydrolysis in the presence of a base; the base is selected from one or more of sodium hydroxide, lithium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, potassium phosphate, potassium carbonate, cesium carbonate, sodium acetate, and potassium acetate in any ratio, and the molar ratio of the base to compound 2 is 1.0:1 to 2.0:

1. The acetic acid hydrolysis reaction is stirred at room temperature until the reaction is complete. After the reaction is completed, the acetic acid solvent is recovered by decompression, and the residual liquid is directly used for the next reaction.

5. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 1, characterized in that: The synthesis of compound 4 is obtained by hydrolysis in the presence of a base, the base is selected from one of sodium hydroxide, lithium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium acetate, potassium acetate, or a mixture of two or more in any ratio, the reaction solvent of the hydrolysis reaction is an organic solvent-water mixed solvent, the organic solvent is a low boiling point solvent miscible with water, the molar ratio of the base in the hydrolysis reaction to the raw material compound 2 in the previous step is 1.0:1 to 3.0:1, and the temperature range of the hydrolysis reaction is 20 to 80°C.

6. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 5, characterized in that: The synthesis of compound 4 is to use compound 2 as the starting material to prepare compound 3 through acetic acid hydrolysis reaction. Compound 3 does not need to be purified. After the acetic acid hydrolysis reaction is complete, the solvent is recovered by reducing pressure, and then water and alkali are directly added to perform hydrolysis reaction to obtain compound 4; In the reaction solvent of the hydrolysis reaction, the organic solvent is selected from at least one of ethanol, methanol, tetrahydrofuran, acetonitrile and acetone, and the volume ratio of the organic solvent to water is 1:0.5-2.

7. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 1, characterized in that: The synthesis of compound 5 is carried out by using the synthesized compound 4 as a starting material, and in the presence of a copper salt ligand and a reaction solvent, using oxygen as an oxygen source to obtain compound 5 by copper salt catalytic oxidation; the copper salt is selected from one of copper acetate, copper sulfate, copper hexafluorophosphate, copper trifluoroacetate, copper chloride, copper bromide, cuprous iodide, cuprous bromide, cuprous chloride, cuprous oxide, and cupric oxide, or a mixture of two or more of them in any ratio, and the amount of the copper salt is 1% to 20% of the molar amount of compound 4, preferably 2.5% to 10%; The copper salt ligand is selected from dinitrogen ligands, that is, at least one of phenanthroline, ethylenediamine, N,N'-di-tert-butylethylenediamine, N,N'-dimethylethylenediamine, N,N,N',N'-tetramethylethylenediamine, bipyridine, bipyridine derivatives, cyclohexanediamine and cyclohexanediamine derivatives. The amount of the copper salt ligand is 100% to 200% of the molar amount of the copper salt; the reaction solvent is at least one of dichloromethane, dichloroethane, chloroform, benzene, toluene, cyclohexane and ethyl acetate. The reaction temperature is 20 to 150°C, preferably 20 to 80°C.

8. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 1, characterized in that: The synthesis of compound 5 is carried out in the presence of DMAP, and the amount of DMAP used is 10-20% of the molar amount of compound 4; after the reaction for synthesizing compound 5 is completed, the following post-treatment steps are also included: filtering, washing the filtrate with 0.5-2N hydrochloric acid and water, drying, concentrating, recrystallizing the residual liquid with chloroform solvent, and filtering and collecting the solid product to obtain compound 5.

9. A method for synthesizing a key intermediate of oxcarbazepine as claimed in claim 1, characterized in that: The method also includes a synthesis step of oxcarbazepine, which is 1O-oxa-10,11-dihydro-5H-diphenyl[b,f]azepine-5-carboxamide. The synthesis of the oxcarbazepine is carried out by using the synthesized compound 5 as a starting material, and acid-catalyzing hydrolysis in an acetic acid solution with sulfuric acid as a catalyst to obtain the target product compound 6 oxcarbazepine. The reaction formula is as follows:

10. A method for synthesizing a key intermediate of oxcarbazepine according to claim 9, characterized in that: After the synthesis reaction of compound 6 is completed, the following post-treatment steps are also included: the reaction solution is poured into ice water, fully stirred, filtered, the filter cake is fully washed with ice water, and dried to obtain a solid product, namely compound 6.

Citation Information

Patent Citations

  • Chemical synthetic method of azepine derivate

    CN101302198A

  • Method for preparing aldehyde or ketone by copper salt / bidentate ligand / TEMPO catalytic air oxidation alcohol

    CN109096068A

  • 5-cyano-10-hydroxy-10,11-dihydro-5h-dibenz[b,f]azepine, the processes for its preparation and for its conversion into 5-carbamoyl-10-oxo-10, 11-dihydro-5h-dibenz[b,f]azepine or into 5-carbamoyl-5h-dibenz[b,f]azepine

    US6384217B1